The Potassium Channels Kv1.3 and KCa3.1 as Targets for Inflammatory Brain Pathologies Professor Heike Wulff, University of California, speaking at Ion Channel Targets 2011.
Alpha2* Nicotinic Acetylcholine Receptors as a Therapeutic Target for Memory Enhancement Dr Katumi Sumikawa, University of California, speaking at Ion Channel Targets 2011.
Smooth Muscle Kv7 (KCNQ) Potassium Channels: Important New Therapeutic Targets Professor Kenneth Byron, Loyola University Chigaco, speaking at Ion Channel Targets 2011.
Protons, Heat and Mechanical Force Converge to Gate Two-Pore Potassium Channels at the Selectivity Filter Dr Slav Bagriantsev, University of California, speaking at Ion Channel Targets 2011.
Background and Key Drivers Leading to Clinical Immunogenicity Dr Matthew Baker, Chief Scientific Officer at Antitope Ltd, speaking at Bioprocessing, Biologics and Biotherapeutics 2011.
The Potential of High Content Imaging in Primary Screening Daniela Siebert, Novartis, speaking at Screening Europe 2011
Challenges for High Content Analysis of Infectious Diseases Anne Danckaert, Institut Pasteur, speaking at Screening Europe 2011
Modeling and Prediction of Antibody Chromatography Purification Professor Christian Frech, Mannheim University of Applied Science, speaking at BioProcessing, Biologics and Biotherapeutics Congress.
A Systematic Investigation of Candidate Breast Cancer Progression-Associated Biomarkers Identified from Omic Screens: Leveraging Antibody-Based Proteomics Prof. William Gallagher, Chief Scientific Officer at OncoMark, speaking at Advances in Microarray Technology 2011.